Fund profile
Fund manager
Total assets
$6.40 mm
Liabilities
$1.41 mm
Net assets
$5.00 mm
Number of holdings
39.00
39 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
TMO Thermo Fisher Scientific Inc. | 367.05 k | 681.00 shares | 7.34 | Common equity | Long | USA |
DHR Danaher Corp. | 348.83 k | 1.45 k shares | 6.98 | Common equity | Long | USA |
NVDA NVIDIA Corp | 307.64 k | 500.00 shares | 6.16 | Common equity | Long | USA |
BIO Bio-Rad Laboratories Inc. - Ordinary Shares | 279.82 k | 872.00 shares | 5.60 | Common equity | Long | USA |
GOOG Alphabet Inc - Ordinary Shares | 275.44 k | 1.97 k shares | 5.51 | Common equity | Long | USA |
COMMON STOCK - ADR
|
210.85 k | 4.14 k shares | 4.22 | Common equity | Long | Denmark |
CTVA Corteva Inc | 197.02 k | 4.33 k shares | 3.94 | Common equity | Long | USA |
ABBV Abbvie Inc | 189.22 k | 1.15 k shares | 3.79 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 183.20 k | 1.41 k shares | 3.67 | Common equity | Long | Denmark |
LULU Lululemon Athletica inc. | 170.64 k | 376.00 shares | 3.41 | Common equity | Long | Canada |
AVTR Avantor Inc. | 168.56 k | 7.33 k shares | 3.37 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 160.76 k | 249.00 shares | 3.22 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 154.62 k | 164.00 shares | 3.09 | Common equity | Long | USA |
BIIB Biogen Inc | 152.68 k | 619.00 shares | 3.06 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 148.56 k | 791.00 shares | 2.97 | Common equity | Long | USA |
DD DuPont de Nemours Inc | 141.65 k | 2.29 k shares | 2.83 | Common equity | Long | USA |
SHORT TERM INV FUND | 141.18 k | 141.18 k shares | 2.83 | Short-term investment vehicle | Long | USA |
COMMON STOCK - ADR
|
113.89 k | 1.71 k shares | 2.28 | Common equity | Long | UK |
EXAS Exact Sciences Corp. | 104.64 k | 1.60 k shares | 2.09 | Common equity | Long | USA |
ORDINARY SHARES
|
104.54 k | 218.00 shares | 2.09 | Common equity | Long | France |
ORDINARY SHARES
|
101.92 k | 983.00 shares | 2.04 | Common equity | Long | Germany |
PPG PPG Industries, Inc. | 101.55 k | 720.00 shares | 2.03 | Common equity | Long | USA |
NGVT Ingevity Corp | 92.78 k | 2.13 k shares | 1.86 | Common equity | Long | USA |
ORDINARY SHARES
|
79.44 k | 4.66 k shares | 1.59 | Common equity | Long | Norway |
TWST Twist Bioscience Corp | 73.71 k | 2.28 k shares | 1.47 | Common equity | Long | USA |
ORDINARY SHARES
|
73.40 k | 731.00 shares | 1.47 | Common equity | Long | France |
VRTX Vertex Pharmaceuticals, Inc. | 72.37 k | 167.00 shares | 1.45 | Common equity | Long | USA |
Bunge Global SA | 65.54 k | 744.00 shares | 1.31 | Common equity | Long | USA |
ORDINARY SHARES
|
65.49 k | 738.00 shares | 1.31 | Common equity | Long | Ireland |
RCKT Rocket Pharmaceuticals Inc | 60.36 k | 2.10 k shares | 1.21 | Common equity | Long | USA |
TECH Bio-Techne Corp | 50.84 k | 723.00 shares | 1.02 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings Inc - Ordinary Shares | 49.94 k | 41.27 k shares | 1.00 | Common equity | Long | USA |
ADM Archer Daniels Midland Co. | 45.52 k | 819.00 shares | 0.91 | Common equity | Long | USA |
LNZA LanzaTech Global Inc - Ordinary Shares | 30.44 k | 6.99 k shares | 0.61 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 29.46 k | 468.00 shares | 0.59 | Common equity | Long | Switzerland |
ALNY Alnylam Pharmaceuticals Inc | 27.32 k | 158.00 shares | 0.55 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 24.09 k | 578.00 shares | 0.48 | Common equity | Long | USA |
ARGX Argen X SE | 23.97 k | 63.00 shares | 0.48 | Common equity | Long | Netherlands |
DNMR Danimer Scientific Inc - Ordinary Shares | 8.88 k | 13.92 k shares | 0.18 | Common equity | Long | USA |